| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Platform: GPL19057
|
Mus musculus
|
TXT
|
Mark Dawson
|
||||
| GSE161657 |
Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (primary leukaemia barcode-seq)
|
|
14 | Mark Dawson | Nov 08, 2021 | |||
| GSE161662 |
Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (NSG vs. BL6 barcode-seq)
|
|
13 |
|
Mark Dawson | Nov 08, 2021 | ||
| GSE161669 |
Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (retransplant barcode-seq)
|
|
10 |
|
Mark Dawson | Nov 08, 2021 | ||
| GSE161672 |
Identifying non-genetic determinants of malignant clonal fitness at single cell resolution (clonal competition barcode-seq)
|
|
39 |
|
Mark Dawson | Nov 08, 2021 | ||
| GSE186303 |
Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [cell of origin barcode-seq]
|
|
96 |
|
Mark Dawson | Nov 08, 2021 | ||
| GSE186304 |
Identifying non-genetic determinants of malignant clonal fitness at single cell resolution [chemo barcode-seq]
|
|
66 |
|
Mark Dawson | Nov 08, 2021 | ||
| GSE129381 |
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq]
|
|
30 |
|
Mark Dawson | Sep 28, 2019 | ||
| GSE110895 |
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia [CRISPR screen]
|
|
1 |
|
Mark Dawson | May 21, 2019 | ||
| GSE110899 |
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia [RNA-seq]
|
|
21 |
|
Mark Dawson | May 21, 2019 | ||
| GSE122843 |
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia [single cell RNA-seq adaptation]
|
|
6 |
|
Mark Dawson | May 21, 2019 |
